NeuroPace (NPCE) Current Deferred Revenue (2020 - 2026)

NeuroPace has reported Current Deferred Revenue for 5 years, with the latest figure at $123000.0 in Q2 2026.

• On a quarterly basis, Current Deferred Revenue fell 82.43% year-over-year to $123000.0 in Q2 2026; TTM through Jun 2026 was $123000.0, a 82.43% decrease from a year earlier, with the FY2025 full-year figure at $141000.0, down 76.5% from the prior year.
• Current Deferred Revenue was $123000.0 for Q2 2026 at NeuroPace, down from $126000.0 in the prior quarter.
• The five-year high for Current Deferred Revenue was $1.1 million in Q4 2023, with the low at $123000.0 in Q2 2026.
• Average Current Deferred Revenue over 4 years is $599727.3, with a median of $700000.0 recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Current Deferred Revenue decreased 13.35% in 2025, then slumped 82.43% in 2026.
• Over 4 years, Current Deferred Revenue stood at $1.1 million in 2023, then sank by 45.45% to $600000.0 in 2024, then tumbled by 76.5% to $141000.0 in 2025, then fell by 12.77% to $123000.0 in 2026.
• The last three Current Deferred Revenue figures came in at $123000.0 (Q2 2026), $126000.0 (Q1 2026), and $141000.0 (Q4 2025), per Business Quant data.